Hemophagocytic syndrome, a rare variant of Still’s disease
DOI:
https://doi.org/10.18203/2320-6012.ijrms20174615Keywords:
AOSD (adult onset stills disease), Fever of unknown origin (FUO)Abstract
Adult onset still’s disease is a rare systemic inflammatory disorder of unknown etiology that is responsible for a significant number of cases of fever of unknown origin (FUO) and musculoskeletal diseases. The diagnosis in adult onset still’s disease is mainly clinical and requires exclusion of other infections. Laboratory tests are nonspecific and treatment mainly comprises of corticosteroids, NSAIDS, immunosuppressive drugs, iv gamma globulin, anti-tumour necrosis factor, anti-interleukin. AOSD (adult onset stills disease) is a diagnostic challenge. Discovery of new serological tests and a specific diagnostic criterion may help the clinician in faster diagnosis and better management of the disease.
Metrics
References
Giampietro C, Fautrel B. Anti-interleukin-1 agents in adult onset Still's disease. Int J Inflammation. 2012;2012.
Jose CC. Martinez-Banos D, Alcocer-Varela J. Adult-onset Still disease as the cause of fever of unknown origin. Medic. 2005;84(6):331-7.
Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):575-80.
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19(3):424-30.
Olive A, Junca J, Tena X. Ferritin and adult Still’s disease. Br J Rheumatol. 1991;30(2):158.
Arvidson NG, Gudbiornsson B, Elfman L, Ryden AC, Totterman, TH, Hallgren R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 1994;53:521-24.
David J, Davies U, Rooney M. Cytokine measurement in juvenile chronic arthritis (JCA). Arthritis Rheum. 1990;33(9):S118-99.
Owlia MB, Mehrpoor G. Adult- onset Still's disease: a review. Indian J Med Sci. 2009;63(5):207-21.
Elliott MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). Br J Rheumatol. 1997;36(5):589-93.
Cavagna L, Caporali R, Epis O, Bobbio-Pllavicini F, Montecucco C. Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19:329-32.
Downloads
Published
How to Cite
Issue
Section
